We may have new hope in the battle against Alzheimer's disease. Researchers have found that lithium levels in the brain are ...

As well as helping to prevent the disease, researchers say their findings could support healthy brain aging in general.

A few limited clinical trials of lithium for Alzheimer’s disease have shown some efficacy, but the lithium compounds they ...

Association of Stages of Objective Memory Impairment With Incident Symptomatic Cognitive Impairment in Cognitively Normal Individuals. Neurology, 2023; Publish Ahead of Print DOI: 10.1212/WNL ...

Stage 1: No impairment (normal function) During this first stage, a person shows no symptoms of Alzheimer’s disease. Memory, thinking, judgment, language, and everyday performance are normal.

In a cohort of midlife adults, mild behavioral impairment may be a reliable marker for impaired executive function, ...

Researchers say the new concept that lithium deficiency could be a cause of Alzheimer’s disease points to a different ...

The FDA has approved Leqembi, the first disease-modifying treatment for early-stage Alzheimer's and a precursor condition, mild cognitive impairment. Medicare has said it will pay for the therapy.

A 2023 review of the pathophysiology of cognitive impairment in MS found that information processing speed, attention, learning, and memory are the most frequently involved domains.

Eating a keto diet prevented the mild cognitive impairment often seen in the early stages of Alzheimer’s disease, new research has found. The researchers suggest that adopting the diet may be a ...

Atai Life Sciences and its partner Recognify Life Sciences said on Friday their experimental drug did not meet the main goal in a mid-stage trial for patients with schizophrenia-linked cognitive ...

A 2023 review of the pathophysiology of cognitive impairment in MS found that information processing speed, attention, learning, and memory are the most frequently involved domains.